Table 2.

Disease-specific outcomes and questionnaires.

Disease group, disease, and questionnaires used		Outcome measure
		Disease activity	Damage	Quality of life	Othera	Indicated time (minutes)
Inflammatory arthritis
	DASb-28c [45]	✓
	Disease damagec		✓			<0.5
	HAQ-DId [46,47]				✓	2.5
	DMARDe side effectsc				✓	<0.5
	BASDAIc,f (spondyloarthritis) [48,49]	✓				1
Inflammatory bowel disease
	IBDg-control-8 [50,51]	✓				1
	iMTAh PCQi [52]			✓		1
	Manitoba IBD Index [53]	✓				0.5
	Montreal classificationc,j [54]			✓		0.5
	Disease damagej		✓			<0.5
	IBDQk [55]j			✓		5.5
	Harvey Bradshaw Index (Crohn disease) [56]j	✓				0.5
Immunology
	BDCAFl,m (Behçet disease) [57]	✓				2.5
	Sarcoidosis disease activityc (sarcoidosis)	✓				0.5
	VFQn-25 (uveitis) [58]			✓		10
	BVASc,o (vasculitis) [59]	✓				0.5
	VDIc,p (vasculitis) [60]		✓			0.5
Dermatology
	ADCTq [61]	✓				0.5
	NRSr disease burdenc		✓			0.5
	DLQIs [62]		✓			1.5
	PGAt or IGAu scalec	✓				<0.5
	PASIc,v (psoriasis) [63]	✓				0.5
	POEMw (atopic dermatitis) [64]	✓				1
	EASIx (atopic dermatitis) [65]	✓				1

^aQuestionnaires involving side effects, physical functionality, and productivity loss.

^bDAS: Disease Activity Score.

^cQuestionnaire reported by physician only.

^dHAQ-DI: Health Assessment Questionnaire Disability Index.

^eDMARD: disease-modifying antirheumatic drug.

^fBASDAI: Bath Ankylosing Spondylitis Disease Activity Index.

^gIBD: inflammatory bowel disease.

^hiMTA: Institute for Medical Technology Assessment.

ⁱPCQ: Productivity Cost Questionnaire.

^jThese questionnaires were asked earlier, but are not part of the questionnaire set anymore.

^kIBDQ: Inflammatory Bowel Disease Questionnaire.

^lBDCAF: Behçet Disease Current Activity Form.

^mQuestionnaire reported by patients and physician.

ⁿVFQ: Visual Function Questionnaire.

^oBVAS: Birmingham Vasculitis Activity Score.

^pVDI: Vasculitis Damage Index.

^qADCT: Atopic Dermatitis Control Tool.

^rNRS: numeric rating scale.

^sDLQI: Dermatology Life Quality Index.

^tPGA: patient global assessment.

^uIGA: Investigator’s Global Assessment.

^vPASI: Psoriasis Area and Severity Index.

^wPOEM: Patient-Oriented Eczema Measure.

^xEASI: Eczema Area and Severity Index.